Epidemiology, antibiotic therapy and clinical outcomes of healthcare-associated pneumonia in critically ill patients: a Spanish cohort study
详细信息 查看全文
- 作者：Jordi Vallés (1) (2) (3)
Ignacio Martin-Loeches (1) (2)
Antoni Torres (2) (4)
Emili Diaz (1) (2)
Iratxe Seijas (5)
Maria José López (6)
Pau Garro (7)
Carlos Castillo (8)
Jose Garnacho-Montero (9)
María del Mar Martin (10)
Maria Victoria de la Torre (11)
Pedro Olaechea (12)
Catia Cilloniz (2) (4)
Jordi Almirall (13)
Fernando García (14)
Roberto Jiménez (15)
Estrella Seoane (16)
Cruz Soriano (17)
Eduard Mesalles (18)
Pilar Posada (19) - 关键词：Healthcare ; associated pneumonia ; Microbial etiology ; Critically ill patient ; ICU
- 刊名：Intensive Care Medicine
- 出版年：2014
- 出版时间：April 2014
- 年：2014
- 卷：40
- 期：4
- 页码：572-581
- 全文大小：274 KB
- 参考文献：1. American Thoracic Society (2005) Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388-16 CrossRef
2. Kollef MH, Shorr A, Tabak YP et al (2005) Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. Chest 128:3854-862 CrossRef
3. Micek ST, Kollef KE, Reichley RM et al (2007) Health-care-associated pneumonia and community-acquired pneumonia: a single-center experience. Antimicrob Agents Chemother 51:3568-573 CrossRef
4. Shindo Y, Sato S, Maruyama E et al (2009) Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest 135:633-40 CrossRef
5. Park HK, Song JU, Um SW et al (2010) Clinical characteristics of health care-associated pneumonia in a Korean teaching hospital. Respir Med 104:1729-735 j.rmed.2010.06.009" target="_blank" title="It opens in new window">CrossRef
6. Carratala J, Mykietiuk A, Fernandez-Sabe N et al (2007) Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 167:1393-399 CrossRef
7. Garcia-Vidal C, Viasus D, Roset A et al (2011) Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization. Clin Microbiol Infect 17:1659-665 j.1469-0691.2011.03484.x" target="_blank" title="It opens in new window">CrossRef
8. Chalmers JD, Taylor JK, Singanayagam A et al (2011) Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin Infect Dis 53:107-13 CrossRef
9. Knaus WA, Draper EA, Wagner DP et al (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-29 CrossRef
10. Vincent JL, Moreno R, Takala J et al (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-10 CrossRef
11. Fine MJ, Auble TE, Yealy DM et al (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243-50 CrossRef
12. Lim WS, van der Eerden MM, Laing R et al (2003) Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 58:377-82 CrossRef
13. Mandell LA, Wunderink RG, Anzueto A et al (2007) Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 44(S2):S27–S72 CrossRef
14. Mahoney FI, Barthel DW (1965) Functional evaluation: the Barthel index. Md State Med J 14:61-5
15. Bell DM (2001) Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention. Clin Infect Dis 33(Suppl 3):S245–S250 CrossRef
16. Clinical and Laboratory Standards Institute (CLSI) (2011). M1000-S21. Performance standards for antimicrobial susceptibility testing: 21st Information Supplement
17. Bagley SC, White H, Golomb BA (2001) Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol 54:979-85 CrossRef
18. Schreiber MP, Chan CM, Shorr AF (2010) Resistant pathogens in nonnosocomial pneumonia and respiratory failure. Is it time to refine the definition of health-care-associated pneumonia. Chest 137:1283-288 CrossRef
19. Venditti M, Falcone M, Corrao S et al (2009) Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital-acquired pneumonia. Ann Intern Med 150:19-6 CrossRef
20. Rello J, Luján M, Gallego M et al (2010) Why mortality is increased in health-care-associated pneumonia: lessons for pneumococcal bacteremic pneumonia. Chest 137:1138-144 CrossRef
21. Sousa D, Justo I, Dominguez A et al (2013) Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome. Clin Microbiol Infect 19:187-92 j.1469-0691.2012.03765.x" target="_blank" title="It opens in new window">CrossRef
22. de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M et al (2013) Outcomes in critically ill cancer patients with septic shock of pulmonary origin. Shock 39:250-54 CrossRef
23. Attridge RT, Frei CR (2011) Health care-associated pneumonia: an evidence-based review. Am J Med 124:689-97 j.amjmed.2011.01.023" target="_blank" title="It opens in new window">CrossRef
24. Kaplan JE, Benson C, Holmes KH et al (2009) Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institute of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58:1-07
25. Segal BH, Freifeld AG, Baden LR et al (2008) Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 6:122-74
26. Polverino E, Torres A, Menendez R et al (2013) Microbial aetiology of health care associated pneumonia (HCAP) in Spain: a prospective, multicenter, case-control study. Thorax 68:1007-014 jnl-2013-203828" target="_blank" title="It opens in new window">CrossRef
27. Grenier C, Pépin J, Nault V et al (2011) Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia. J Antimicrob Chemother 66:1617-624 jac/dkr176" target="_blank" title="It opens in new window">CrossRef - 作者单位：Jordi Vallés (1) (2) (3)
Ignacio Martin-Loeches (1) (2)
Antoni Torres (2) (4)
Emili Diaz (1) (2)
Iratxe Seijas (5)
Maria José López (6)
Pau Garro (7)
Carlos Castillo (8)
Jose Garnacho-Montero (9)
María del Mar Martin (10)
Maria Victoria de la Torre (11)
Pedro Olaechea (12)
Catia Cilloniz (2) (4)
Jordi Almirall (13)
Fernando García (14)
Roberto Jiménez (15)
Estrella Seoane (16)
Cruz Soriano (17)
Eduard Mesalles (18)
Pilar Posada (19)
1. Area de Patología Crítica, Critical Care Department, Hospital de Sabadell, Corporació Sanitaria Universitaria Parc Taulí, Parc Taulí s/n, Sabadell, Spain
2. CIBER de Enfermedades Respiratorias (Ciberes), Madrid, Spain
3. Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
4. Servicio de Pneumologia, Hospital Clínic i Provincial de Barcelona, IDIBAPS, Barcelona, Spain
5. Servicio de Medicina Intensiva, Hospital Universitario Cruces, Bilbao, Spain
6. Servicio de Medicina Intensiva, Hospital General de Burgos, Burgos, Spain
7. Servicio de Medicina Intensiva, Hospital de Granollers, Granollers, Spain
8. Servicio de Medicina Intensiva, Hospital Txagoritxu, Vitoria, Spain
9. Unidad Clínica de Cuidados Críticos y Urgencias, Hospital Universitario Virgen del Rocío, Seville, Spain
10. Servicio de Medicina Intensiva, Hospital Universitario Nuestra Sra, Candelaria, Tenerife, Spain
11. Servicio de Medicina Intensiva, Hospital Virgen de la Victoria, Málaga, Spain
12. Servicio de Medicina Intensiva, Hospital Galdakao, Galdakao, Spain
13. Servicio de Medicina Intensiva, Hospital de Mataró, Barcelona, Spain
14. Servicio de Medicina Intensiva, Hospital General Universitario de Albacete, Albacete, Spain
15. Servicio de Medicina Intensiva, Hospital Universitario Santa Lucía, Cartagena, Murcia, Spain
16. Servicio de Medicina Intensiva, Complexo Hospitalario Universitario de Ourense, Ourense, Spain
17. Servicio de Medicina Intensiva, Hospital La Paz, Madrid, Spain
18. Servicio de Medicina Intensiva, Hospital Germans Trias i Pujol, Badalona, Spain
19. Servicio de Medicina Intensiva, Complejo Hospitalario Universitario de Vigo, Vigo, Spain - ISSN：1432-1238
文摘
Purpose Information about healthcare-associated pneumonia (HCAP) in critically ill patients is scarce. Methods This prospective study compared clinical presentation, outcomes, microbial etiology, and treatment of HCAP, community-acquired pneumonia (CAP), and immunocompromised patients (ICP) with severe pneumonia admitted to 34 Spanish ICUs. Results A total of 726 patients with pneumonia (449 CAP, 133 HCAP, and 144 ICP) were recruited during 1?year from April 2011. HCAP patients had more comorbidities and worse clinical status (Barthel score). HCAP and ICP patients needed mechanical ventilation and tracheotomy more frequently than CAP patients. Streptococcus pneumoniae was the most frequent pathogen in all three groups (CAP, 34.2?%; HCAP, 19.5?%; ICP, 23.4?%; p?=?0.001). The overall incidence of Gram-negative pathogens, methicillin-resistant Staphylococcus aureus (MRSA), and Pseudomonas aeruginosa was low, but higher in HCAP and ICP patients than CAP. Empirical treatment was in line with CAP guidelines in 73.5?% of patients with CAP, in 45.5?% of those with HCAP, and in 40?% of those with ICP. The incidence of inappropriate empirical antibiotic therapy was 6.5?% in CAP, 14.4?% in HCAP, and 21.8?% in ICP (p?<?0.001). Mortality was highest in ICP (38.6?%) and did not differ between CAP (18.4?%) and HCAP (21.2?%). Conclusions HCAP accounts for one-fifth of cases of severe pneumonia in patients admitted to Spanish ICUs. The empirical antibiotic therapy recommended for CAP would be appropriate for 90?% of patients with HCAP in our population, and consequently the decision to include coverage of multidrug-resistant pathogens for HCAP should be cautiously judged in order to prevent the overuse of antimicrobials.